This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.2% to $9.71 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.1% to 22,017.85 and the Dow Jones Industrial Average falling 0.2% to 46,584.46.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 52.8% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 6.9% to $7.45, Fortress Biotech Inc. fell 6.4% to $2.35, and Viking Therapeutics Inc. fell 0.68% to $33.70.
Trading volume totaled 252,116, compared to the 50-day average of 195,951.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 07, 2026 16:34 ET (20:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments